The Broad Effects of Chronic Kidney Disease
Chronic kidney disease impacts multiple organs and overall health.
Dunja Aksentijevic, M. Young, M. Aastrup, N. Patel, F. Cullen, E. S. S. Hansen, J. E. Clark, T. R. Eykyn, M. Vaeggemose, A. Vujic, L. Karatzia, L. Valkovic, J. J. J. J. Miller, N. H. Buus, C. Laustsen, M. M. Yaqoob
― 6 min read
Table of Contents
- The Impact of CKD
- Heart Problems Linked to CKD
- The Whole Body Effects of CKD
- The Relationship Between Kidneys and Other Organs
- Investigating the Causes of Heart Issues in CKD
- Animal Studies on CKD
- The Effects of CKD on Muscles
- Changes in Kidney Structure and Function
- Liver Changes Due to CKD
- Human Studies on CKD Patients
- Conclusion
- Original Source
Chronic Kidney Disease (CKD) is a condition where the kidneys gradually lose their ability to function properly over time. This can lead to kidney failure, a serious health problem that affects millions of people around the world. CKD is often unnoticed until it is too late, and it can be linked to various health issues, including heart disease.
The Impact of CKD
CKD affects an estimated 840 million people globally. In the UK, about 10% of the population, or around 7.2 million people, are thought to have CKD. This situation represents a significant public health issue with an annual financial impact of approximately £7 billion on the UK healthcare system. Projections indicate that as more people develop CKD, these costs may double within the next ten years. The demand for dialysis treatment, a common therapy for advanced kidney failure, is also expected to rise by 400%.
Heart Problems Linked to CKD
For many individuals with CKD, the risk of developing heart disease is often greater than the risk of progressing to kidney failure. One specific heart issue related to CKD is called uraemic cardiomyopathy. This problem affects how the heart pumps blood, causing changes like left ventricular hypertrophy (enlargement of the heart’s main pumping chamber) and issues with heart muscle function. Patients with CKD frequently experience changes in how their hearts use energy, making it difficult for them to handle stress, such as exercise or heart attacks.
The Whole Body Effects of CKD
CKD does not just affect the kidneys; it can lead to problems in other organs too. When kidneys don’t work well, it can cause changes in various Metabolic processes in the body. This includes insulin resistance, muscle wasting, and changes in how the kidneys themselves process nutrients. CKD can create a situation where patients face multiple health risks at once, including inflammation and problems with the heart, blood vessels, and bones. The health of Skeletal Muscles is especially important as they play a vital role in overall health and physical function in CKD patients.
The Relationship Between Kidneys and Other Organs
The decline in kidney function can greatly affect the liver and vice versa. As kidneys struggle, they can create a buildup of harmful substances in the blood, overwhelming the liver’s ability to filter them out. This connection between the kidneys and liver is crucial because both organs are essential for maintaining a healthy body.
When kidney function decreases, it can lead to problems like altered sugar and fat metabolism, and this creates a cycle of worsening health in CKD patients. The metabolic issues often seen in these patients add additional strain to both the kidneys and liver, further complicating their health status.
Investigating the Causes of Heart Issues in CKD
Since the factors behind uraemic cardiomyopathy are complex, it is unclear whether the metabolic changes occurring in CKD play a role in this heart condition. Research has shown that the energy levels in skeletal muscles reflect the energy levels in the heart. This suggests that changes in metabolism related to CKD could influence heart health. Therefore, understanding the metabolic alterations in CKD could help clarify some of the issues related to uraemic cardiomyopathy.
Animal Studies on CKD
To investigate the relationship between CKD, heart function, and general health, researchers used two different animal models. One model involved giving rats a diet with a substance that induces CKD over four weeks, while the other model involved a surgical procedure to remove part of the kidney over a twelve-week period. Both models demonstrated that kidney problems, regardless of how they were induced, lead to changes in heart and body metabolism, making the hearts less able to recover from stress.
In these studies, researchers used advanced techniques to analyze the metabolism of various organs such as the liver, muscles, and kidneys. They found significant changes in how these organs used energy and dealt with stress. Both models of CKD showed marked changes in metabolism that were linked to heart problems.
The Effects of CKD on Muscles
CKD also causes damage to skeletal muscles, which is evident in the experimental animal models. In rats with CKD, there was a noticeable increase in a substance that indicates muscle damage, along with weight loss that suggests muscle wasting. These changes affect the overall physical health of the animals, making them weaker.
Metabolic profiling of these muscles showed a drop in energy reserves and an increase in amino acids, which indicates that the muscles were struggling to function properly due to the kidney disease. This situation was especially severe in the first model but was also seen in the second model to a lesser extent.
Changes in Kidney Structure and Function
Both CKD models showed significant changes in the kidneys. In the adenine diet model, both kidneys underwent severe damage, leading to noticeable changes in size and function. In contrast, the partial nephrectomy model showed that while one kidney was surgically removed, the remaining kidney often enlarged to compensate for the loss of function.
The metabolic analysis of the kidneys in both models revealed substantial disturbances, particularly in the adenine diet model. Many metabolites were altered, suggesting severe kidney dysfunction.
Liver Changes Due to CKD
CKD impacts the liver as well. In both models of CKD, liver weight was reduced, indicating potential liver damage. Furthermore, analysis highlighted metabolic changes in the Livers of CKD animals, with noticeable alterations in how the liver processed nutrients and toxins. These changes can have widespread consequences throughout the body, linking liver health with kidney health.
Human Studies on CKD Patients
To further understand these metabolic problems, researchers assessed human patients with CKD through a specialized technique that measures energy use in muscles during exercise. They found that while the resting energy levels of CKD patients seemed normal, these patients could not use their energy reserves effectively during physical activity. They produced less force during exertion compared to healthy individuals, suggesting a significant problem with muscle performance.
The results indicated that the energy supply in the muscles of CKD patients was not just about having enough energy but also about the ability to use that energy efficiently. This inefficiency may contribute to the fatigue and muscle weakness commonly seen in CKD patients.
Conclusion
CKD is a complex condition that affects more than just the kidneys. It has a profound impact on overall health, linking kidney function with heart, liver, and muscle health. Understanding the intricate relationships between these organs and how CKD alters their function can help pave the way for new treatment strategies that could improve the quality of life for patients.
More research is needed to fully grasp the metabolic changes occurring in CKD and how these relate to other health issues. Enhanced understanding of these dynamics could lead to better monitoring of patients and new approaches to treatment that consider the whole body, not just the kidneys. Through such efforts, it may be possible to reduce the burden of CKD and the associated risks to overall health.
Title: Altered systemic bioenergetic reserve in chronic kidney disease predisposes hearts to worse functional outcomes
Abstract: Chronic kidney disease (CKD) is the tenth biggest killer worldwide and is projected to be the fifth leading cause of mortality by 2040. CKD is an inherently systemic disease with progressive deterioration of kidney, muscle, and liver function creating a vicious cycle of comorbidity. However, whether systemic energetic deficiency in CKD contributes to cardiac dysfunction of the uraemic cardiomyopathy remains unknown. Using two pre-clinical renal failure models of different aetiology in rats (4-week 0.75% adenine diet and 12-week post-partial nephrectomy) we investigated both cardiac and systemic metabolic remodelling in CKD. In addition to significant uraemia, anaemia and alterations in exogenous plasma substrate homeostasis, non-targeted 1H NMR spectroscopy metabolomic profiling of peripheral tissues (skeletal muscle, liver, kidneys) revealed extensive metabolic alterations and changes in bioenergetic reserve in both experimental CKD models. Similarly, 31P magnetic resonance spectroscopy assessment of the exercising lower leg muscle of CKD human patients identified systemic bioenergetic deficiency. During exercise CKD patients were unable to utilise the energetic capacity to the same extent as healthy controls. Both experimental CKD models developed mild cardiac dysfunction, however metabolic remodelling was less severe than that of systemic organs. Upon challenge with 25-minute total global ischemia, CKD hearts from both experimental models had poorer functional outcome. Thus, in CKD perturbation of systemic metabolism precedes and exceeds severity of cardiac metabolic changes. Prevention of systemic metabolic derangement in CKD may be a new therapeutic approach to improve cardiac functional outcomes in CKD. One Sentence SummaryPerturbations of systemic metabolism precede and exceed severity of cardiac metabolic changes in chronic kidney disease.
Authors: Dunja Aksentijevic, M. Young, M. Aastrup, N. Patel, F. Cullen, E. S. S. Hansen, J. E. Clark, T. R. Eykyn, M. Vaeggemose, A. Vujic, L. Karatzia, L. Valkovic, J. J. J. J. Miller, N. H. Buus, C. Laustsen, M. M. Yaqoob
Last Update: 2024-10-29 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.10.24.620055
Source PDF: https://www.biorxiv.org/content/10.1101/2024.10.24.620055.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.